Chronic Phase
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| EPIgenetics and in Vivo Resistance of Chronic Myeloid Leukemia Stem Cells to Tyrosine Kinase Inhibitors (NCT03481868) | University Hospital, Clermont-Ferrand | 2018-02-01 |
| Activity and Risk Profile of Ponatinib in Chronic Phase Patients With Chronic Myeloid Leukemia Resistant to Imatinib (NCT02398825) | Gruppo Italiano Malattie EMatologiche dell'Adulto | 2016-06-23 |
Track Chronic Phase automatically
Every clearance here is in the API, with alerts when new ones post.